Hope for Patients with NASH
Автор: Pfizer
Загружено: 2018-06-26
Просмотров: 18610
Описание:
Approximately 30% of adults in the U.S. have fatty liver, and 15% of them will progress to having nonalcoholic steatohepatitis (NASH). At Pfizer, we’re striving to use our expertise in metabolic disorders to develop treatments that have the potential to significantly improve the lives of patients with NASH.
Hope for Patients with NASH
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: